known
chr
helix
half
buri
hydrophob
groov
two
adjac
helic
nhr
homotrim
assembl
socal
fusion
core
care
examin
previous
report
crystal
structur
notic
outsid
nhr
hydrophob
groov
solvent
expos
hydrophob
pocket
locat
around
nterminu
nhr
close
bind
site
chr
fig
sinc
ntermin
hydrophob
pocket
nthp
lie
hydrophob
groov
cover
canon
chr
chrderiv
peptid
fig
nthp
majorli
compos
four
hydrophob
residu
includ
one
nhr
helix
adjac
nhr
helix
fig
amino
acid
sequenc
align
show
residu
highli
conserv
among
differ
strain
fig
impli
previous
undescrib
pocket
could
potenti
target
enhanc
inhibitori
potenc
cp
peptid
creat
ctermin
tail
possess
interact
ntermin
hydrophob
pocket
nthp
truncat
chrderiv
peptid
result
cp
fig
number
two
threeresidu
tail
incorpor
hydrophob
side
chain
ration
design
fit
shape
nthp
includ
ileaspleu
sermet
sertrp
lead
peptid
inhibitor
cpidl
cpsm
cpsw
respect
subsequ
four
peptid
without
design
tail
togeth
artifici
synthes
subject
assess
antivir
activ
fig
c
origin
cp
peptid
low
inhibitori
activ
clinic
strain
subtyp
ae
subtyp
nm
nm
respect
expect
presenc
artifici
ctermin
tail
inhibitori
activ
elong
cp
rais
differ
extend
cpidl
show
highest
potenc
increas
respect
moreov
enhanc
activ
cpidl
stronger
two
strain
compar
inhibitori
activ
cp
cpidl
isol
includ
virus
tabl
show
cpidl
could
inhibit
infect
differ
type
pseudoviru
valu
nm
nm
much
potent
cp
peptid
fold
fold
fold
fold
test
inhibitori
activ
cp
cpidl
resist
strain
tabl
show
cpidl
could
inhibit
infect
resist
strain
much
potent
cp
fact
potenc
cp
inhibitor
could
remark
improv
ctermin
idl
tail
impli
threeresidu
tail
bind
nhr
novel
interact
pattern
classic
helixgroov
one
explor
exact
bind
mode
artifici
idl
tail
first
determin
crystal
structur
fusion
peptid
nhr
peptid
wide
employ
structur
studi
fusion
core
unexpectedli
welldefin
electron
densiti
fig
show
whole
cpidl
fold
continu
fig
perfectli
superimpos
peptid
structur
fig
despit
signific
differ
tail
sequenc
counterpart
ileaspleu
glulysasn
fig
form
almost
one
turn
helix
isoleucin
aspart
acid
residu
idl
locat
outer
side
henc
interact
leucin
residu
particip
hydrophob
interact
two
adjac
nhr
helic
respect
fig
interfac
area
one
cpidl
trimer
nhr
idl
tail
contribut
approxim
addit
notic
nterminu
plenti
space
allow
residu
nhr
interact
idl
tail
structur
featur
unveil
structur
idl
design
target
ntermin
hydrophob
pocket
nthp
mainli
compos
trimer
contain
intact
nthp
target
therefor
determin
crystal
structur
longer
nterminu
contain
whole
target
nthp
fig
final
model
although
cp
portion
still
fold
idl
tail
adopt
total
differ
conform
form
hooklik
structur
pack
ntermin
hydrophob
pocket
nthp
fig
design
side
chain
orient
isoleucin
leucin
residu
idl
tail
toward
nhr
trimer
possess
hydrophob
interact
conserv
hydrophob
residu
nthp
includ
nhr
helix
within
fusion
peptid
adjac
nhr
helix
hydrophil
aspart
acid
residu
idl
tail
also
form
interact
nhr
contribut
side
chain
oxygen
atom
form
salt
bridg
side
chain
nitrogen
atom
fig
besid
three
tail
residu
conform
chang
also
influenc
side
chain
orient
residu
prior
idl
tail
result
hydrogen
bond
main
chain
oxygen
atom
stabil
hooklik
idl
tail
consequ
structur
bind
one
cpidl
lead
buri
surfac
area
idl
hooklik
tail
contribut
approxim
larger
contribut
helic
idl
tail
structur
compar
helic
form
hooklik
idl
exhibit
extens
interact
nhr
henc
like
repres
natur
conform
cpidl
bind
homotrimer
nhr
worth
note
structur
contain
chain
fusion
peptid
within
one
asymmetr
unit
form
two
structur
chain
gener
ident
rm
deviat
respect
tabl
conform
differ
ignor
solv
structur
space
group
assign
first
result
unaccept
refin
statist
rfree
reassign
space
group
solv
problem
final
model
six
idl
tail
one
asymmetr
unit
adopt
similar
hooklik
conform
differ
bfactor
tabl
indic
flexibl
bind
nhr
trimer
even
one
six
helic
idl
tail
miss
final
model
consid
structur
compactli
pack
one
anoth
lead
direct
interact
idl
tail
adjac
fig
b
necessari
investig
whether
idl
structur
observ
artifici
state
result
crystal
pack
assess
stabil
two
idl
conform
molecular
dynam
md
simul
perform
two
model
crystal
structur
respect
well
isol
cpidl
peptid
two
structur
run
ns
conduct
hooklik
structur
idl
tail
gener
retain
posit
ctermin
residu
assess
calcul
varianc
distanc
nhr
within
fusion
peptid
averag
distanc
shown
fig
residu
idl
tail
tightli
fix
residu
prior
two
residu
idl
tail
flexibl
howev
interfac
area
hooklik
idl
tail
nhr
trimer
roughli
stabl
rang
contribut
interfac
cpidl
nhr
fig
interestingli
total
interfac
area
three
idl
tail
stabl
individu
tail
possess
contribut
fig
idl
tail
analysi
hydrogenbond
respons
conform
cterminu
show
helic
conform
could
stabil
run
ns
fig
howev
without
presenc
nhr
trimer
neither
helic
hooklik
structur
idl
tail
could
maintain
ns
run
perform
peptid
movi
conclus
md
simul
indic
idl
tail
separ
cpidl
peptid
tend
bear
disord
conform
alter
stabl
helic
hooklik
structur
bind
short
long
nhr
helic
respect
fusion
core
critic
target
antiviru
fusion
inhibitor
peptid
deriv
chr
henc
helic
conform
mani
approach
proven
effect
improv
inhibitor
includ
mutant
screen
chemic
modif
conjug
protein
none
howev
ration
design
alter
helic
conform
origin
inhibitor
target
novel
bind
site
hydrophob
groov
two
adjac
nhr
helic
recent
multipl
studi
show
motif
nonhel
structur
also
capabl
improv
potenc
helic
fusion
inhibitor
even
could
crucial
helix
antihiv
chrderiv
peptid
hooklik
structur
form
two
nativ
ntermin
chr
residu
could
increas
antivir
activ
modifi
unmodifi
previous
publish
work
relat
middl
east
respiratori
syndrom
coronaviru
base
crystal
structur
fusion
core
success
design
effect
inhibitori
peptid
two
nonhel
tail
end
extrem
necessari
antivir
present
work
show
novel
case
ration
design
nonhel
ctermin
idl
tail
capabl
effect
enhanc
potenc
chrderiv
inhibitor
form
hooklik
structur
tightli
pack
nthp
novel
bind
site
close
canon
hydrophob
groov
recent
progress
suggest
ad
nonhel
tail
n
cterminu
might
valid
univers
strategi
improv
antivir
potenc
fusion
inhibitor
idl
tail
fusion
inhibitor
crystallograph
observ
two
distinguish
conform
oneturn
helix
hooklik
structur
given
idl
hook
crystal
longer
nhr
peptid
contribut
larger
interfac
area
helic
one
believ
structur
hooklik
idl
tail
like
repres
natur
conform
cpidl
nhr
complex
solut
howev
accord
md
simul
result
helic
hooklik
structur
idl
tail
stabil
interact
nhr
trimer
consid
shift
residu
two
conform
respect
fig
conform
transit
two
state
seem
imposs
spontan
occur
assembl
previou
studi
confirm
isol
cp
peptid
show
low
indic
end
rel
disord
agreement
md
simul
isol
cpidl
peptid
therefor
propos
combin
homotrimer
nhr
idl
tail
free
cpidl
peptid
gener
disord
alter
rel
order
hooklik
structur
bind
nhr
trimer
sinc
hooklik
tail
conform
similar
previous
disord
tail
decad
sinc
first
hiv
fusion
inhibitor
target
prove
us
fda
antihiv
agent
combin
therapi
howev
recent
year
shortcom
limit
clinic
applic
includ
lower
antihiv
activ
shorter
halflif
expens
synthet
cost
emerg
necessari
design
new
upgrad
inhibitor
better
inhibitori
activ
shorter
length
reduc
synthet
cost
artifici
sequenc
differ
chr
enlarg
bind
target
result
kind
ration
design
obtain
fusion
inhibitor
hooklik
idl
tail
innov
solut
problem
similar
inhibitor
addit
compar
aa
cpidl
shorter
length
aa
possess
notabl
reduc
synthet
cost
doubt
cpidl
potenti
candid
develop
new
antihiv
fusion
inhibitor
clinic
applic
moreov
result
highlight
advantag
artifici
design
peptid
could
wide
employ
develop
artifici
peptidebas
viru
fusion
inhibitor
envelop
virus
class
membran
fusion
protein
panel
peptid
fig
includ
cp
cpsm
cpsw
cpidl
synthes
standard
solidphas
fmoc
method
describ
peptid
found
pure
hplc
identifi
mass
spectrometri
persept
biosystem
framingham
usa
concentr
peptid
determin
uv
absorb
theoret
calcul
molarextinct
coeffici
base
tryptophan
tyrosin
residu
inhibit
activ
peptid
infect
clinic
strain
determin
previous
inhibit
subtyp
ae
subtyp
viru
ad
cell
rpmi
medium
contain
fb
presenc
absenc
test
peptid
overnight
cultur
supernat
chang
fresh
media
fourth
day
postinfect
cultur
supernat
collect
detect
antigen
elisa
percent
inhibit
product
calcul
use
comput
program
calcusyn
use
overlap
pcr
dna
fragment
encod
cpidl
peptid
attach
cdna
nhr
short
linker
sggrgg
whole
sequenc
subclon
vector
novagen
usa
e
coli
cell
induc
ad
mm
iptg
incub
overnight
fusion
protein
purifi
ninta
affin
resin
qiagen
valencia
ca
usa
trxtag
cleav
presciss
proteas
enzym
treatment
h
purifi
appli
onto
gel
filtrat
column
ge
healthcar
piscataway
nj
usa
fraction
contain
trimer
collect
concentr
differ
concentr
ultrafiltr
fusion
protein
crystal
use
hang
drop
vapordiffus
method
drop
set
silicon
cover
clip
equilibr
mixtur
contain
protein
solut
mgml
trimer
mm
trishcl
ph
mm
nacl
reservoir
solut
nacl
citric
acid
ph
wv
peg
reservoir
solut
one
week
singl
crystal
form
flash
frozen
liquid
nitrogen
futur
data
collect
fusion
protein
crystal
similar
way
differ
reservoir
solut
sodium
potassium
phosphat
ph
two
week
singl
crystal
form
flash
frozen
liquid
nitrogen
futur
data
collect
dataset
collect
inhous
xray
sourc
micromax
xray
gener
rigaku
japan
institut
biophys
chines
academi
scienc
xray
diffract
data
integr
scale
use
phase
problem
three
structur
solv
molecular
replac
method
use
crystal
structur
hiv
nhrchr
pdb
entri
search
model
final
model
manual
adjust
refin
space
group
first
assign
one
peptid
one
asymmetr
unit
howev
lead
unaccept
statist
rfree
problem
solv
reassign
space
group
six
chain
one
asymmetr
unit
coordin
deposit
protein
data
bank
statist
data
collect
structur
refin
given
tabl
preliminari
md
simul
model
protein
perform
use
program
namd
nanoscal
molecular
dynam
program
v
forc
file
gener
use
visual
molecular
dynam
vmd
contain
chain
b
c
structur
chosen
initi
model
hydrogen
atom
coordin
model
gener
autopsf
plugin
vmd
protein
model
solvat
water
box
layer
water
molecul
direct
ioniz
sodium
chlorid
ion
physiolog
concentr
model
subject
energi
minim
step
follow
restrain
npt
equilibr
ns
isobar
isotherm
condit
maintain
atm
k
subsequ
product
simul
conduct
equilibr
model
proper
durat
ns
integr
time
step
fs
structur
isol
cpidl
peptid
model
subject
md
simul
fashion
describ
simul
run
perform
scgrid
supercomput
environ
chines
academi
scienc
visual
extract
raw
trajectori
data
analysi
perform
use
vmd
assess
stabil
interact
idl
tail
combin
nhr
trimer
averag
distanc
ctermin
residu
cpidl
nhr
residu
calcul
varianc
distanc
simul
run
monitor
plot
addit
contribut
idl
tail
buri
area
also
calcul
monitor
simul
run
buri
area
simpli
consid
one
half
solvent
access
surfac
area
differ
complex
b
sum
b
calcul
solvent
access
surfac
typic
probe
radiu
employ
two
tcl
script
code
perform
vmd
tk
consol
realiz
calcul
describ
cite
articl
zhu
et
al
ration
improv
fusion
inhibitor
innov
design
ileaspleu
tail
altern
conform
sci
rep
doi
